Resting-state fMRI markers of conversion to dementia in amnestic MCI: a pilot studyEUROPEAN PSYCHIATRYIF6.72023-07-190OAAI
The mass spectrometry study of blood plasma proteome changes associated with Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Why (not) go east? comparison of FDA inspections from cee, we and us investigational site inspectionsEUROPEAN PSYCHIATRYIF6.72020-04-150PREAI
Comparative efficacy and safety of antidepressive mono- and multimodal therapy with citicoline in elderly patients with depression in psychogeriatric unitEUROPEAN PSYCHIATRYIF6.72020-03-231PREAI
Mental Disorders in Elderly Patients with Fracture of the Femoral Neck or the FemurEUROPEAN PSYCHIATRYIF6.72015-03-010PREAI
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multicenter trialINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82014-03-1678OAAI
Helping carers to care-The 10/66 Dementia Research Group's randomized control trial of a caregiver intervention in RussiaINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82008-09-2376PREAI
The protocols for the 10/66 dementia research group population-based research programmeBMC PUBLIC HEALTHIF3.62007-07-20277OAAI
New approaches to Alzheimer's disease therapy: role of neurotrophic stimulationEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72005-01-010PREAI